Table 2.
A list of studies for patient selection eligible for HT and their crude incidence in different countries
| No. | Country | New cancer cases and RT candidates | Incidence of candidates for PT on 100,000 | Incidence of candidates for p+ on 100,000 | Incidence of candidates for C-ions on 100,000 |
|---|---|---|---|---|---|
| 1 | Austria (6) |
New = 36,500 RT = 15,132 (41%) |
HT = 13.5% of RT | HT = 2044 (all Austria) population (2004) = 8.2 million 25 cases on 100,000 |
|
| 2 | Italy (5) |
25,000 new radioresistant tumors | 10%-15% of radioresistant = 3000-4000 cases | Population 57.5 million population (2005) 6.9 cases on 100,000 |
|
| 3 | Iran (29) |
2,932 cases 1,943 for RT 66% of cancer cases |
HT = 22.9% of RT |
5,756 eligible for HT, entire Iran Population 78.5 million population (2018) 7.3 cases on 100,000 |
|
| 4 | France (4) |
One day study (5 clinics); survey on 532 RT candidates |
HT =77/532 RT HT= 14.5% of RT |
5.320 eligible for HT, entire France Population 65.5 million population (2013) 8.5 cases on 100,000 |
|
| 5 | France (5) |
HT = 12% of RT | 7 cases on 100,000 | 5 cases on 100,000 | |
| 7500 eligible for HT, entire France Population 64 million population (2006) 12 cases on 100,000 | |||||
| 5 | Sweden (20) |
31,050 cases 7,650 for RT 25% of cancer cases |
HT = 15% of RT | 2,475 eligible for HT, all Sweden Population (2005) = 9 million 28 cases on 100,000 |
|
| 6 | Yellow report (7) |
First priority protons: 0.8 cases on 100,000 | First priority C-ions: 2 cases on 100,000 |
||
| Second priority: 5 cases on 100,000 I and II priority: 7.8 cases on 100,000 | |||||
| 7 | S. Korea (8) |
4000 eligible for C-ions, all S. Korea Population (2018) = 51.6 million 7.8 cases on 100,000 |
|||
Abbreviations: HT = Hadron therapy; PT = particle therapy; RT = radiation therapy.